Information Provided By:
Fly News Breaks for October 16, 2019
LLY
Oct 16, 2019 | 16:54 EDT
BofA/Merrill analyst Geoff Meacham reinstated coverage of Eli Lilly with a Buy rating and $133 price target. The analyst sees the company's "high quality, differentiated growth and modest expectations for added pipeline value" as compelling.